A second COVID-19 vaccine now also appears highly effective in preventing illness following exposure to the virus that causes the disease.

The biotech company Moderna, Inc., said Monday that its experimental vaccine was 94.5% effective in preventing disease, according to an analysis of its clinical trial.

There were 95 instances of COVID-19 illness among the study participants — only five of those cases were in the vaccinated group. Ninety were in the group receiving the placebo. Of these, there were 11 cases of severe disease. The results indicate the vaccine was inducing the kind of immune response that protects people if they were exposed to the coronavirus.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stéphane Bancel, chief executive officer of Moderna, in a statement.

Moderna said it intends to file “in the coming weeks” with the FDA for authorization of the company’s vaccine for emergency use.

The federal Operation Warp Speed project to hasten development of COVID-19 vaccines awarded Moderna a $1.5 billion contract in August to ramp up manufacturing and deliver 100 million vaccine doses, enough for 50 million people. The government has an option to buy up to 400 million more doses.

Moderna said Monday that it expects to be able to ship about 20 million vaccine doses in the U.S. by the end of 2020. Next year, the company said it expects to be able to make 500 million to 1 billion doses worldwide.

U.S. consumer sentiment unexpectedly declined in early November as an increase in COVID-19 infections and the election prompted Americans to reassess their outlooks for the economy and finances.

The University of Michigan’s preliminary sentiment index for November decreased to a three-month low of 77 from a final October reading of 81.8, data released Nov. 13 showed. The median estimate in Bloomberg’s survey of economists called for a reading of 82.

The measure of expectations dropped by nearly 8 points to 71.3, while a gauge of current conditions was little changed at 85.8. Interviews conducted following the election recorded a substantial negative shift in Republicans’ expectations and no gain among Democrats. The survey began Oct. 28 and concluded late Nov. 10.

While broadband is nearly universal in Wisconsin cities and villages, there are major disparities in the rural parts of the state, according to a new Forward Analytics report, Broadband in Rural Wisconsin: Identifying Gaps, Highlighting Successes.

The most recent data from the Federal Communications Commission show that 25% of rural residents lack access to 25 Mbps broadband, the speed which is now considered the standard. Wisconsin’s level of inaccessibility is worse than the national average and 35 other states.

In Wisconsin, rural access to 25 Mbps broadband varies widely by county. The highest levels of access generally are in the relatively small rural parts of urban counties, such as Kenosha, Racine, and Waukesha counties. However, in nine more sparsely-populated counties—Ashland, Clark, Douglas, Iron, Marinette, Price, Richland, Rusk, and Taylor—less than half of the rural population had broadband at that speed available in 2019.

According to Knapp, Wisconsin’s broadband infrastructure does have key successes, though. Access levels at speeds of 10 Mbps or higher are better than the U.S. average—93.6% of rural Wisconsin residents had access to those speeds vs. 91.3% nationally. In areas with high levels of 10 Mbps access, the strategy for achieving universal 25 Mbps access will focus more on upgrading current service rather than bringing new broadband to areas where it does not exist.

Last night, Governor Tony Evers delivered a primetime address, calling for unity and working together in responding to the COVID-19 pandemic. The governor’s address comes as Wisconsin had yet another record-breaking day in COVID-19 cases, hospitalizations, and deaths.

As COVID-19 continues to surge across the state, Governor Evers announced Executive Order #94, which includes new measures to combat the spread of COVID-19. Executive Order #94 advises Wisconsinites to stay home, urges precautions Wisconsinites should take to stay safe if they have to leave their home, and encourages businesses to take additional steps to protect workers, customers, and the surrounding community

The Wisconsin Supreme Court will hear oral arguments on November 16 regarding whether the state legislature can yield its power to the executive branch in the challenge to Governor Tony Evers’ Covid-19 emergency powers.

The Wisconsin Institute for Law & Liberty (WILL) has been granted time for oral arguments in the case of Fabick v. Evers, an original action before the state Supreme Court questioning whether Evers can issue multiple emergency orders for the same crisis, the continuing fight against the Covid-19 pandemic. According to WILL, the power to extend the emergency orders only belongs to the legislature.

Since the start of the Covid-19 pandemic, Evers has issued three emergency orders that have been challenged in court.

The first order was the shut down of bars, restaurants and other “non-essential” businesses earlier this year. The Evers Administration’s attempt to extended that emergency order was shot down 5-4 in a state Supreme Court decision in a lawsuit brought by WILL.

The emergency order that authorized the statewide mask mandate is before the Wisconsin Supreme Court now in Fabick v. Evers. WILL had filed their own separate lawsuit, but their case was put on hold and they were invited to file an amicus brief in the Fabick case.

A third emergency order limiting occupancy for bars and restaurants to 25% was defeated at the Appeals Court level on Friday. The order, which also expired on Friday, was placed on hold by the Appeals Court in October pending the final outcome of the case.

The Department of Workforce Development (DWD) was recently notified by the United States Department of Labor (USDOL) that Wisconsin has met the criteria for turning off the Unemployment Insurance (UI) Extended Benefits (EB) program. The last payable week of EB is November 7, 2020.

According to the USDOL, “Wisconsin’s 13-week insured unemployment rate (IUR) for the week ending October 10, 2020, was 4.87 percent, falling below the 5.00 percent threshold necessary to remain “on” EB. Therefore, the EB period for Wisconsin ended on November 7, 2020 and the State will remain in an “off” period for a minimum of 13 weeks.”

DWD expects to complete system programming for the EB program in December. Once complete, eligible claimants will be paid for the weeks in which they qualify for the benefit retroactively.

For more information, visit https://dwd.wisconsin.gov/uiben/eb/.

Wednesday, the Supreme Court of Wisconsin voted not to consider whether to reinstate the governor’s order that limited indoor capacity and imposed gathering restrictions.

The order, which Gov. Tony Evers issued in October, is not currently in effect. Gov. Evers noted Wednesday that the back-and-forth is only hurting the state’s ability to get the virus under control.

Wisconsin Attorney General Josh Kaul had asked the state’s highest court to consider reinstating the order, which caps indoor public gatherings at 25% occupancy or 10 people if an occupancy restriction is not in place.

The order was blocked by the 3rd District Court of Appeals in October after Pro-Life Wisconsin and a bar in Amery appealed a circuit court judge’s decision to uphold the capacity limit.

The decision stemmed from a lawsuit filed against the state by the Tavern League of Wisconsin. The governor’s chief legal counsel, Ryan Nilsestuen, said he plans to appeal Wednesday’s outcome.

More than a dozen retail pharmacy chains have agreed to partner with the federal government to serve as COVID-19 vaccination sites under a plan developed by the U.S. Centers for Disease Control and Prevention.

Walgreens Boots Alliance Inc., CVS Health Corp., Walmart Inc., Kroger Co., Publix Super Markets Inc., and Costco Wholesale Corp. are among the companies that have agreed to participate, according to the CDC plan issued Friday.

The information was contained in an updated “interim playbook” the CDC prepared for states, territories, and local governments readying vaccination programs.

The playbook sketches out how Covid-19 shots would get to hospitals, clinics, and other vaccination sites, starting with initial supplies for health-care workers and others at high risk of infection.

Pharmacies would become involved during a second phase of vaccine rollout. The pharmacies would order the Covid-19 vaccines from the federal government, which would then supply them, according to the CDC’s plan. The pharmacies’ involvement would help expand and accelerate the public’s access to the shots as supplies increase, the CDC said.